Adani Ports breaks out at record Rs 1,747 as 500 MMT milestone meets Hormuz reroute trade (NSE: ADANIPORTS)
Read More Pharma Industry News Lumosa Therapeutics reports Phase 2 functional gains for LT3001 in disabling acute ischemic stroke Lumosa Therapeutics’ LT3001 Phase 2 stroke data show functional gains beyond standard windows. Find out what this means for Phase 3 and investors. bySrinathFebruary 8, 2026